Tag: venous thromboembolism

Behind the procedure: Removing in-stent thrombosis with the RevCore Thrombectomy Catheter

This advertorial is sponsored by Inari Medical. For patients with in-stent thrombosis (IST), one of the most critical unmet needs has been an effective method...
pregnancy

Child-bearing age ‘should not be a contraindication to venous stenting’

In a recently published study, dedicated venous stents performed well through pregnancy and postpartum, and a protocol including the use of low-dose antiplatelets in...

Study finds similar rates of VTE in both flying and non-flying...

Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper,...
filters

New study demonstrates IVC filters ‘safe and effective’ in treating venous...

Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...

Key differences in presentation, outcomes for distal versus proximal DVT uncovered

A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...

Compression duration affects pain during superficial venous intervention, study finds

Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...

CLTI, VTE and post-thrombotic syndrome: Leading experts discuss crucial decision-making in...

This advertorial is sponsored by ACHL. For Anahita Dua, MBChB, the stark realities and complexities of peripheral arterial disease (PAD) patients undergoing endovascular treatment for...

Strength in numbers: Global VASCC COVID-19 project helps identify framework to...

When Robert Cuff, MD, and Max Wohlauer, MD, first launched the Vascular Surgery COVID-19 Collaborative (VASCC) back in the spring of 2020, the pandemic...

FDA approves two pediatric venous thromboembolism indications for rivaroxaban

The Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent...

Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical

Surmodics recently announced that it has acquired privately-held Vetex Medical Limited, expanding the company's thrombectomy portfolio with a second Food and Drug Administration (FDA) 510(k)-cleared...

Janssen submits new drug application to FDA for rivaroxaban to treat...

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced it has submitted a new drug application (NDA) to the Food and Drug Administration...

Adjunctive compression to standard prophylaxis for postoperative VTE shows benefit in...

Among patients with a Caprini score of ≥11 who received standard prophylaxis for venous thromboembolism (VTE), adjunctive intermittent pneumatic compression (IPC) resulted in a significantly...

Vascular surgery COVID-19 registry participants probe state of practice amid winter...

The question of the COVID-19 pandemic’s effect on vascular practice continues to occupy members of the specialty. Contributors to a global vascular surgery registry...

AHA, ISTH release joint statement on future VTE research priorities

The American Heart Association (AHA) and the International Society on Thrombosis and Haemostasis (ISTH) issued a joint scientific statement July 8 outlining research priorities...

Women are at a higher risk of iliac vein stent failure,...

A recent study on iliac vein stenting showed lower long-term patency rates for women when compared to their male counterparts. The data were presented...

Special COVID-19 session added to SVS ONLINE slate

SVS ONLINE will now feature a session that hones in on the coronavirus pandemic, consisting of nine talks dealing with such issues as acute...

AHA issues call to action to prevent VTE in hospitalised patients

Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the U.S. and worldwide. A new policy statement from the American Heart...

Registry launches pair of studies on vascular complications related to COVID-19

The new Vascular Surgery COVID-19 Collaborative (VASCC) is ready to start collecting data on two projects. The first study to emerge from the international registry,...